Fatigue Among Short- and Long-term Thyroid Cancer Survivors: Results from the Population-based PROFILES Registry
Overview
Authors
Affiliations
Background: The aims of this study were (i) to obtain insight into the prevalence of fatigue among short- and long-term thyroid cancer (TC) survivors, by comparing a sample of TC survivors with an age- and sex-matched normative population, and (ii) to investigate which demographic, clinical, and TC-specific health-related quality of life (HRQoL) characteristics were associated with fatigue.
Methods: All patients found to have TC between 1990 and 2008, as registered in the Eindhoven Cancer Registry, received a cross-sectional survey on fatigue (Fatigue Assessment Scale), TC-specific HRQoL (THYCA-QoL), and psychological distress (Hospital Anxiety and Depression Scale). The fatigue scores were compared with those of an age- and sex-matched normative population (n=530). Multiple logistic regression analyses were conducted to investigate the independent associations between clinical and demographic characteristics, TC-specific HRQoL, and psychological distress with fatigue.
Results: Eighty-six percent (n=306) responded. TC survivors were more often classified as fatigued or very fatigued (short-term <5 years: 43%; long-term 5-10 years: 44%; long-term 10-15 years: 47%; long-term >15 years: 39%) compared to the normative population (25%; p<0.001). Anxiety (odds ratio (OR) 1.15, 95% confidence interval [CI] 1.03-1.28) and depression (OR 1.43 [CI 1.22-1.68]) were associated with fatigue, as was also the case for TC-specific neuromuscular (OR 1.03 [CI 1.01-1.06]), concentration (OR 1.03 [CI 1.01-1.06]), and psychological TC-specific HRQoL (OR 1.06 [CI 1.02-1.10]).
Conclusion: Short- and long-term TC survivors report higher levels of fatigue than an age- and sex-matched normative population do. Both TC-specific HRQoL and psychological distress were associated with fatigue.
Changchien T, Yen Y, Lu Y J Clin Med. 2024; 13(18).
PMID: 39336959 PMC: 11432333. DOI: 10.3390/jcm13185472.
Liu L, Xiang Y, Xiong L, Li C, Dai W, Hu J Front Psychol. 2024; 15:1329175.
PMID: 39176053 PMC: 11339645. DOI: 10.3389/fpsyg.2024.1329175.
Xiong L, Liu L, Xiang Y, Li C, Dai W, Hu J Int J Surg. 2024; 111(1):1311-1329.
PMID: 39028114 PMC: 11745735. DOI: 10.1097/JS9.0000000000001974.
A meta-analysis of total thyroidectomy and lobectomy outcomes in papillary thyroid microcarcinoma.
Bi J, Zhang H Medicine (Baltimore). 2023; 102(50):e36647.
PMID: 38115346 PMC: 10727648. DOI: 10.1097/MD.0000000000036647.
Thanh Vy T, Le Thi Thanh Nam T, Cuong L, Bang H Cureus. 2023; 15(6):e40496.
PMID: 37461749 PMC: 10349926. DOI: 10.7759/cureus.40496.